MTST (MetaStat) ROC (Joel Greenblatt) %: -1,030.92% (As of Feb. 2018)


What is MetaStat ROC (Joel Greenblatt) %?

MetaStat MTST ROC (Joel Greenblatt) % is -1,030.92% as of Feb. 2018.

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. MetaStat's annualized ROC (Joel Greenblatt) % for the quarter that ended in Feb. 2018 was -1,030.92%.

The historical rank and industry rank for MetaStat's ROC (Joel Greenblatt) % or its related term are showing as below:

MTST's ROC (Joel Greenblatt) % is not ranked *
in the Biotechnology industry.
Industry Median: -297.06
* Ranked among companies with meaningful ROC (Joel Greenblatt) % only.

MetaStat's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.


MetaStat  (OTCPK:MTST) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


MetaStat ROC (Joel Greenblatt) % Related Terms


MetaStat ROC (Joel Greenblatt) % Historical Data

* Premium members only.

The historical data trend for MetaStat's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MetaStat ROC (Joel Greenblatt) % Chart

MetaStat Annual Data
Trend Feb09 Feb10 Feb11 Feb12 Feb13 Feb14 Feb15 Feb16 Feb17 Feb18
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4,068.48 -2,013.95 -847.07 -412.06 -796.36

MetaStat Quarterly Data
May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Aug16 Nov16 Feb17 May17 Aug17 Nov17 Feb18
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 593.12 -243.87 -741.34 -1,175.26 -1,030.92

MTST vs OBMP, NSPX, ATRX: ROC (Joel Greenblatt) % Comparison

For the Biotechnology subindustry, MetaStat's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MetaStat ROC (Joel Greenblatt) % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MetaStat's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where MetaStat's ROC (Joel Greenblatt) % falls into.



MetaStat ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Nov. 2017 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0.071) - (0.879 + 0.025 + 0)
=-0.833

Working Capital(Q: Feb. 2018 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0.015) - (1.08 + 0 + 0)
=-1.065

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of MetaStat for the quarter that ended in Feb. 2018 can be restated as:

ROC (Joel Greenblatt) %(Q: Feb. 2018 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Nov. 2017  Q: Feb. 2018
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-3.768/( ( (0.377 + max(-0.833, 0)) + (0.354 + max(-1.065, 0)) )/ 2 )
=-3.768/( ( 0.377 + 0.354 )/ 2 )
=-3.768/0.3655
=-1,030.92 %

Note: The EBIT data used here is four times the quarterly (Feb. 2018) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROC (Joel Greenblatt) % of -1,030.92% mean?
MetaStat (MTST) has a ROC (Joel Greenblatt) % of -1,030.92% as of Feb. 2018. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on MetaStat and its competitors.
Is MetaStat's ROC (Joel Greenblatt) % too high?
MetaStat's current ROC (Joel Greenblatt) % is -1,030.92%.
How does MetaStat's ROC (Joel Greenblatt) % compare to OBMP and NSPX?
MetaStat's ROC (Joel Greenblatt) % of -1,030.92% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Biotechnology company?
A good ROC (Joel Greenblatt) % depends on the Biotechnology industry context. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on MetaStat and its competitors. MetaStat's current ROC (Joel Greenblatt) % is -1,030.92%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MetaStat stock overvalued right now?
MetaStat (MTST) has a current ROC (Joel Greenblatt) % of -1,030.92%. The current ROC (Joel Greenblatt) % is -1,030.92%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For MetaStat (MTST), the current ROC (Joel Greenblatt) % is -1,030.92% as of Feb. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MetaStat Business Description

Address 27 Drydock Avenue, 2nd Floor, Boston, MA, USA, 02210
MetaStat Inc is a us-based biotechnology company which focuses on discovering and developing personalized therapeutic (Rx) and diagnostic (Dx) treatment solutions for cancer patients. The company focuses on development programs of the novel therapeutic product candidates that target the Mena protein isoform whereas the Companion Diagnostics program is focused on developing companion tests to be used in combination with cancer drugs, that provide essential information for the safe and effective use of a corresponding drug or biological product to improve patient outcome. It also develops a prognostic diagnostic program which is focused on developing diagnostic tests that predict the risk of future metastasis in cancer patients following the initial treatment of their primary tumor.